Pseudotargeted lipidomics analysis of scoparone on glycerophospholipid metabolism in non-alcoholic steatohepatitis mice by LC-MRM-MS
Authors:
Open Access
Abstract
As the inflammatory subtype of nonalcoholic fatty liver disease (NAFLD), the progression of nonalcoholic steatohepatitis (NASH) is associated with disorders of glycerophospholipid metabolism. Scoparone is the major bioactive component in Artemisia capillaris which has been widely used to treat NASH in traditional Chinese medicine. However, the underlying mechanisms of scoparone against NASH are not yet fully understood, which hinders the development of effective therapeutic agents for NASH. Given the crucial role of glycerophospholipid metabolism in NASH progression, this study aimed to characterize the differential expression of glycerophospholipids that is responsible for scoparone’s pharmacological effects and assess its efficacy against NASH. Liquid chromatography-multiple reaction monitoring-mass spectrometry (LC-MRM-MS) was performed to get the concentrations of glycerophospholipids, clarify mechanisms of disease, and highlight insights into drug discovery. Additionally, pathologic findings also presented consistent changes in high-fat diet-induced NASH model, and after scoparone treatment, both the levels of glycerophospholipids and histopathology were similar to normal levels, indicating a beneficial effect during the observation time. Altogether, these results refined the insights on the mechanisms of scoparone against NASH and suggested a route to relieve NASH with glycerophospholipid metabolism. In addition, the current work demonstrated that a pseudotargeted lipidomic platform provided a novel insight into the potential mechanism of scoparone action.Keywords
Funding Information
- Natural Science Foundation of Hebei Province (H2019201426)
- Science and Technology Project of Hebei Education Department (QN2021017)
- Medical Science Foundation of Hebei University (2021A08)
- College Students’ Innovative Entrepreneurial Training Plan Program (2022379)
This publication has 37 references indexed in Scilit:
- Lysophosphatidylcholine disrupts cell adhesion and induces anoikis in hepatocytesFEBS Letters, 2022
- Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute‐on‐Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid–Dependent Monocyte ActivationHepatology, 2021
- Scoparone alleviates hepatic fibrosis by inhibiting the TLR‐4/NF‐κB pathwayJournal of Cellular Physiology, 2020
- Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophagesBiomedicine & Pharmacotherapy, 2020
- Nonalcoholic SteatohepatitisJAMA, 2020
- Simultaneous quantification of free fatty acids and acylcarnitines in plasma samples using dansylhydrazine labeling and liquid chromatography–triple quadrupole mass spectrometryAnalytical and Bioanalytical Chemistry, 2020
- L-α-Phosphatidylcholine attenuates mercury-induced hepato-renal damage through suppressing oxidative stress and inflammationEnvironmental Science and Pollution Research, 2019
- Scoparone attenuates hepatic stellate cell activation through inhibiting TGF-β/Smad signaling pathwayBiomedicine & Pharmacotherapy, 2017
- The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and diseaseBiochimica et Biophysica Acta (BBA) - Biomembranes, 2017
- Bioactive aldehyde-modified phosphatidylethanolaminesBiochimie, 2013